Trial intelligence / Profile preview

Esomeprazole vs Omeprazole for Maintenance of Healed Reflux Esophagitis

NCT00634114Phase 3Completed

Sponsor
AstraZeneca
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of esomeprazole in reflux esophagitis, sponsored by AstraZeneca. Started Jan 2008; status: completed.

02

Drugs

esomeprazole
03

Conditions

reflux esophagitis

Beyond the preview

Go deeper on NCT00634114.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00634114.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call